Potential statin drug interactions in elderly patients: a review
I Damiani, A Corsini, S Bellosta - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction Persons aged more than 65 years may be more prone to suffer from chronic
diseases and comorbidities (as demonstrated by the recent COVID-19 pandemics) and are …
diseases and comorbidities (as demonstrated by the recent COVID-19 pandemics) and are …
Antipsychotic treatment in elderly patients on polypharmacy with schizophrenia
M Stuhec - Current Opinion in Psychiatry, 2022 - journals.lww.com
Elderly patients with SCH on polypharmacy are less frequently studied, although they
represent many patients with SCH. Different potentially inappropriate medication lists and …
represent many patients with SCH. Different potentially inappropriate medication lists and …
Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India
BACKGROUND: Adverse drug reactions account for the highest proportion among the
causes of morbidity and mortality in clinical wards and are posing a considerable challenge …
causes of morbidity and mortality in clinical wards and are posing a considerable challenge …
[HTML][HTML] Comorbidity drives mortality in newly diagnosed heart failure: a study among geriatric outpatients
I Oudejans, A Mosterd, NP Zuithoff, AW Hoes - Journal of cardiac failure, 2012 - Elsevier
BACKGROUND: Elderly heart failure (HF) patients frequently have multiple comorbidities.
The prognostic impact of combined comorbidities is poorly quantified in these patients. We …
The prognostic impact of combined comorbidities is poorly quantified in these patients. We …
Medication review and enhanced information transfer at discharge of older patients with polypharmacy: a cluster-randomized controlled trial in swiss hospitals
T Grischott, Y Rachamin, O Senn, P Hug… - Journal of general …, 2023 - Springer
Background Medication safety in patients with polypharmacy at transitions of care is a focus
of the current Third WHO Global Patient Safety Challenge. Medication review and …
of the current Third WHO Global Patient Safety Challenge. Medication review and …
Beta-blocker use in older hospitalized patients affected by heart failure and chronic obstructive pulmonary disease: an Italian survey from the REPOSI Register
V Arcoraci, F Squadrito, M Rottura… - Frontiers in …, 2022 - frontiersin.org
Beta (β)-blockers (BB) are useful in reducing morbidity and mortality in patients with heart
failure (HF) and concomitant chronic obstructive pulmonary disease (COPD). Nevertheless …
failure (HF) and concomitant chronic obstructive pulmonary disease (COPD). Nevertheless …
Factors associated with prolonged length of stay for elective hepatobiliary and neurosurgery patients: a retrospective medical record review
Background Patients with prolonged length of hospital stay (LOS) not only increase their
risks of nosocomial infections but also deny other patients access to inpatient care …
risks of nosocomial infections but also deny other patients access to inpatient care …
Predictors of polypharmacy among elderly Thais with depressive and anxiety disorders: findings from the DAS study
N Wongpakaran, T Wongpakaran, T Sirirak… - BMC geriatrics, 2018 - Springer
Background Polypharmacy is a geriatric syndrome defined variously as the use of potentially
inappropriate drugs and/or the concurrent use of multiple medications including prescription …
inappropriate drugs and/or the concurrent use of multiple medications including prescription …
[HTML][HTML] Avaliação de fatores determinantes do tempo de internação em clínica médica
GP Rufino, MG Gurgel, TC Pontes… - Rev. Soc. Bras. Clín …, 2012 - pesquisa.bvsalud.org
OBJETIVOS: A qualidade da assistência à saúde é prejudicada diante do longo tempo de
permanência hospitalar, relacionado às características e à procedência do paciente. O …
permanência hospitalar, relacionado às características e à procedência do paciente. O …
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid …
Objective To evaluate whether polypharmacy is associated with treatment response and
serious adverse events (SAEs) in patients with RA using data from the British Society for …
serious adverse events (SAEs) in patients with RA using data from the British Society for …